243 related articles for article (PubMed ID: 16584714)
1. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate.
Kim EJ; Kang DO; Love DC; Hanover JA
Carbohydr Res; 2006 Jun; 341(8):971-82. PubMed ID: 16584714
[TBL] [Abstract][Full Text] [Related]
2. Structure and mechanism of a bacterial beta-glucosaminidase having O-GlcNAcase activity.
Dennis RJ; Taylor EJ; Macauley MS; Stubbs KA; Turkenburg JP; Hart SJ; Black GN; Vocadlo DJ; Davies GJ
Nat Struct Mol Biol; 2006 Apr; 13(4):365-71. PubMed ID: 16565725
[TBL] [Abstract][Full Text] [Related]
3. Location and characterization of the O-GlcNAcase active site.
Toleman C; Paterson AJ; Kudlow JE
Biochim Biophys Acta; 2006 May; 1760(5):829-39. PubMed ID: 16517082
[TBL] [Abstract][Full Text] [Related]
4. Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants.
Cetinbaş N; Macauley MS; Stubbs KA; Drapala R; Vocadlo DJ
Biochemistry; 2006 Mar; 45(11):3835-44. PubMed ID: 16533067
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors.
Macauley MS; Whitworth GE; Debowski AW; Chin D; Vocadlo DJ
J Biol Chem; 2005 Jul; 280(27):25313-22. PubMed ID: 15795231
[TBL] [Abstract][Full Text] [Related]
6. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
Wells L; Gao Y; Mahoney JA; Vosseller K; Chen C; Rosen A; Hart GW
J Biol Chem; 2002 Jan; 277(3):1755-61. PubMed ID: 11788610
[TBL] [Abstract][Full Text] [Related]
7. Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.
Lazarus BD; Love DC; Hanover JA
Glycobiology; 2006 May; 16(5):415-21. PubMed ID: 16434389
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
[TBL] [Abstract][Full Text] [Related]
9. An O-GlcNAcase-specific inhibitor and substrate engineered by the extension of the N-acetyl moiety.
Kim EJ; Perreira M; Thomas CJ; Hanover JA
J Am Chem Soc; 2006 Apr; 128(13):4234-5. PubMed ID: 16568991
[TBL] [Abstract][Full Text] [Related]
10. The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity.
Lee TN; Alborn WE; Knierman MD; Konrad RJ
Biochem Pharmacol; 2006 Sep; 72(6):710-8. PubMed ID: 16844097
[TBL] [Abstract][Full Text] [Related]
11. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.
Gao Y; Wells L; Comer FI; Parker GJ; Hart GW
J Biol Chem; 2001 Mar; 276(13):9838-45. PubMed ID: 11148210
[TBL] [Abstract][Full Text] [Related]
12. Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog.
Toleman C; Paterson AJ; Shin R; Kudlow JE
Biochem Biophys Res Commun; 2006 Feb; 340(2):526-34. PubMed ID: 16376298
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities.
Toleman C; Paterson AJ; Whisenhunt TR; Kudlow JE
J Biol Chem; 2004 Dec; 279(51):53665-73. PubMed ID: 15485860
[TBL] [Abstract][Full Text] [Related]
14. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
Forsythe ME; Love DC; Lazarus BD; Kim EJ; Prinz WA; Ashwell G; Krause MW; Hanover JA
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11952-7. PubMed ID: 16882729
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.
Dong DL; Hart GW
J Biol Chem; 1994 Jul; 269(30):19321-30. PubMed ID: 8034696
[TBL] [Abstract][Full Text] [Related]
16. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of a group A streptococcal glycoside hydrolase Spy1600 from family 84 reveals it is a beta-N-acetylglucosaminidase and not a hyaluronidase.
Sheldon WL; Macauley MS; Taylor EJ; Robinson CE; Charnock SJ; Davies GJ; Vocadlo DJ; Black GW
Biochem J; 2006 Oct; 399(2):241-7. PubMed ID: 16822234
[TBL] [Abstract][Full Text] [Related]
18. Cloning of the gene of beta-N-acetylglucosaminidase from Lactobacillus casei ATCC 27092 and characterization of the enzyme expressed in Escherichia coli.
Senba M; Kashige N; Nakashima Y; Miake F; Watanabe K
Biol Pharm Bull; 2000 May; 23(5):527-31. PubMed ID: 10823657
[TBL] [Abstract][Full Text] [Related]
19. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells.
Hanover JA; Lai Z; Lee G; Lubas WA; Sato SM
Arch Biochem Biophys; 1999 Feb; 362(1):38-45. PubMed ID: 9917327
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of beta-N-acetylhexosaminidase from rice seeds.
Jin YL; Jo YY; Kim KY; Shim JH; Kim YW; Park RD
J Biochem Mol Biol; 2002 May; 35(3):313-9. PubMed ID: 12297015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
